AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

11,230.00p
   
  • Change Today:
    -186.00p
  • 52 Week High: 13,276.00
  • 52 Week Low: 9,725.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.61m
  • Volume: 127,406
  • Market Cap: £174,133m
  • RiskGrade: 123

Latest ShareCast News

AstraZeneca makes regulatory progress with Imfinzi, Calquence

By Josh White

Date: Monday 31 Mar 2025

AstraZeneca ShareCast News

AstraZeneca spending $2.5bn on new R&D centre, b... 21-Mar-2025 ShareCast
AstraZeneca buys biotech firm Esobiotec for up t... 17-Mar-2025 ShareCast
AstraZeneca hails trial results for imfinzi on g... 07-Mar-2025 ShareCast
AstraZeneca's Imfinzi gets recommended for fresh... 03-Mar-2025 ShareCast
AstraZeneca's camizestrant shows promise in brea... 26-Feb-2025 ShareCast

AstraZeneca Regulatory News

Calquence recommended for EU approval in 1L MCL 31-Mar-2025 07:05 RNS
Imfinzi approved in the US for bladder cancer 31-Mar-2025 07:00 RNS
AZN invests $2.5bn in Beijing R&D & manufacturing 21-Mar-2025 10:58 RNS
Eneboparatide Phase III trial met primary endpoint 17-Mar-2025 07:10 RNS
Imfinzi approved in EU for limited-stage SCLC 17-Mar-2025 07:05 RNS

AstraZeneca Newspaper Links

AstraZeneca scrapped £450m plant after governmen... 19-Mar-2025 Times
Fighting Frenchman shows us how as he ensures As... 30-Dec-2014 Daily Mail
Exclusive: UK firms vie for share of £170bn in A... 08-Dec-2014 The Independent
MARKET REPORT: Ariad on the up amid growing spec... 04-Dec-2014 Daily Mail
Some reasons why Pfizer won’t bid for AstraZenec... 19-Nov-2014 Guardian

AstraZeneca Tips & Analysis

Questor :AstraZeneca 29-Apr-2014 Telegraph
Questor : AstraZeneca 24-Jan-2014 Telegraph
Questor:AstraZeneca 22-Dec-2011 Telegraph
Investment Column:AstraZeneca 28-Oct-2011 The Independent
Investment Column: AstraZeneca 23-Jun-2011 The Independent

AstraZeneca News Wires

MedImmune Announces Zook as President 13-Nov-2008 PR Newswire
Survey Shows Lung Cancer Patients Blamed for The... 12-Nov-2008 PR Newswire
CRESTOR Demonstrates Dramatic CV Risk Reduction ... 09-Nov-2008 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 11,230.00p
Change Today -186.00p
% Change -1.63 %
52 Week High 13,276.00
52 Week Low 9,725.00
Volume 127,406
Shares Issued 1,550.61m
Market Cap £174,133m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
93.34% below the market average93.34% below the market average93.34% below the market average93.34% below the market average93.34% below the market average
87.23% below the sector average87.23% below the sector average87.23% below the sector average87.23% below the sector average87.23% below the sector average
Price Trend
41.51% above the market average41.51% above the market average41.51% above the market average41.51% above the market average41.51% above the market average
51.02% above the sector average51.02% above the sector average51.02% above the sector average51.02% above the sector average51.02% above the sector average
Income
65.81% below the market average65.81% below the market average65.81% below the market average65.81% below the market average65.81% below the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
Growth
85.34% above the market average85.34% above the market average85.34% above the market average85.34% above the market average85.34% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 15
Neutral 4
Sell 0
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 20-Feb-25 08-Aug-24
Paid 24-Mar-25 09-Sep-24
Amount 210.00¢ 100.00¢

Trades for 31-Mar-2025

Time Volume / Share Price
11:24 39 @ 11,230.00p
11:24 22 @ 11,226.64p
11:24 32 @ 11,228.00p
11:24 27 @ 11,232.00p
11:24 40 @ 11,232.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page